Article
Benchmarking analysis of deleterious SNP prediction tools on CYP2D6 enzyme.
Chemical biology & drug design - 1 Sept 2020
Ferreira Karla Cristina do Vale, Fialho Leonardo Ferreira, Franco Octávio Luiz, de Alencar Sérgio Amorim, Porto William Farias
Abstract excerpt
The cytochrome P450 family is composed of hemeproteins involved in the metabolic transformation of endogenous and exogenous substances. The CYP2D6 enzyme is responsible for the metabolism of ~25% of clinically used drugs and is mainly expressed in the liver. The CYP2D6 gene is known to have a large number of single nucleotide polymorphisms (SNPs). Nevertheless, these variations could modify the CYP2D6 enzyme's...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
